GSW "hi I`m an investor from HotCopper could I please get an update on the status of FDA approval for your wonderful oraline product"
receptionist to director "sir we have another one of those day trading clowns from HC wanting some info"
director "FFS do they think we sit around all day waiting for questions from guys who want to know whether to hold shares for 2 minutes or 5 minutes"
director "just send him the usual b.ullsh.ite automated response email"
receptionist "yes sir"
email : dear gsw thankyou for your inquiry we enjoy fielding questions from investors please find answers below:
ORALINE DRUG TEST CERTIFIED FOR EXPORT TO MEXICO Harrington Group (ASX: HGR) is pleased to advise that the Company’s subsidiary Sun Biomedical Laboratories (SBL) has been granted a certificate of exportability from the U.S. Food and Drug Administration (FDA). This enables the export of OraLine IV, the Company’s premier oral fluid illicit drug screening device, into Mexico. Subject to acceptance by the Mexican government, the Company anticipates commencement of shipping of OraLine IV in September 2007. A significant distribution partner to SBL, Express Diagnostics, has been working with the Mexican government where it is intended that OraLine IV will be used for testing programs being implemented in the Mexican schools system. In its war against illicit drugs the Mexican government has introduced mandatory drug testing in schools. The Company is confident that the Mexican market will deliver significant volumes and that the model of mandatory testing in schools is likely to be adopted in other markets. As previously advised the Company remains committed to, and continues to work toward the realisation of FDA 510(k) clearance for OraLine IV for workplace testing programs in the U.S. For further information contact Brian Andrews – Managing Director
HGR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.